MMP1 and cancer: These results clearly indicate that salivary MMP-1 levels in patients with poorly or moderately differentiated cancer are higher than those in patients with undifferentiated or well-differentiated cancers, with a median fold-difference of 4.5- or 1.4-fold (p < 0.05) (Figure 4E).